-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Upgrades Incyte to Outperform, Raises Price Target to $144

Benzinga·10/30/2026 09:27:00
Listen to the news
Oppenheimer analyst Jay Olson upgrades Incyte (NASDAQ:INCY) from Perform to Outperform and raises the price target from $120 to $144.